IvermectinForLess.com

5.9K posts

IvermectinForLess.com banner
IvermectinForLess.com

IvermectinForLess.com

@IVERMECTlN

US Katılım Ağustos 2010
3.7K Takip Edilen2.3K Takipçiler
IvermectinForLess.com
IvermectinForLess.com@IVERMECTlN·
@ShiningScience @RoyauteBretonne Awesome breakthrough. If this research truly helps retrain the immune system instead of simply suppressing it, it could change the future for millions suffering from autoimmune diseases worldwide.
English
0
0
1
448
Shining Science
Shining Science@ShiningScience·
In a monumental medical breakthrough, scientists have won the Nobel Prize for discovering how to stop the human immune system from attacking its own body. This revolutionary finding could transform the treatment of autoimmune diseases such as lupus, type 1 diabetes, and multiple sclerosis. The immune system is designed to defend us from harmful invaders, but sometimes it turns against healthy cells, triggering chronic inflammation and organ damage. The Nobel-winning research identified the molecular “switches” that control immune tolerance—essentially teaching the body to recognise what is self and what is not. By resetting these mechanisms, doctors may soon be able to treat or even prevent autoimmune diseases at their root, without suppressing the entire immune system. Early trials show that this approach can restore normal immune balance while keeping the body strong against infections. This discovery could end decades of suffering for millions affected by conditions once considered incurable. It’s not just a medical milestone—it’s proof that the human body holds the key to its own healing.
Shining Science tweet media
English
21
155
354
45.1K
IvermectinForLess.com
IvermectinForLess.com@IVERMECTlN·
𝗖𝗨𝗥𝗘 𝗛𝗜𝗗𝗗𝗘𝗡 𝗪𝗜𝗧𝗛𝗜𝗡 𝗨𝗦: 𝗧𝗵𝗲 𝗜𝗺𝗺𝘂𝗻𝗲 𝗦𝘆𝘀𝘁𝗲𝗺’𝘀 𝗢𝘄𝗻 𝗥𝗲𝘀𝗲𝘁 𝗕𝘂𝘁𝘁𝗼𝗻 This article says that scientists have made a groundbreaking discovery showing how the immune system can be taught to stop attacking the body’s own healthy tissues. The Nobel Prize-winning research uncovered key molecular “switches” that regulate immune tolerance — helping the body distinguish between friend and foe. The findings could transform the future of autoimmune disease treatment, including lupus, multiple sclerosis, and type 1 diabetes. Instead of broadly suppressing immunity, this new approach aims to restore balance at the root cause while still allowing the body to defend itself against infections. Early research suggests it may be possible to “reset” the immune system and reduce chronic inflammation without damaging normal immune function. For millions living with autoimmune diseases, this discovery offers new hope that the body itself may contain the mechanisms needed for healing.
Shining Science@ShiningScience

In a monumental medical breakthrough, scientists have won the Nobel Prize for discovering how to stop the human immune system from attacking its own body. This revolutionary finding could transform the treatment of autoimmune diseases such as lupus, type 1 diabetes, and multiple sclerosis. The immune system is designed to defend us from harmful invaders, but sometimes it turns against healthy cells, triggering chronic inflammation and organ damage. The Nobel-winning research identified the molecular “switches” that control immune tolerance—essentially teaching the body to recognise what is self and what is not. By resetting these mechanisms, doctors may soon be able to treat or even prevent autoimmune diseases at their root, without suppressing the entire immune system. Early trials show that this approach can restore normal immune balance while keeping the body strong against infections. This discovery could end decades of suffering for millions affected by conditions once considered incurable. It’s not just a medical milestone—it’s proof that the human body holds the key to its own healing.

English
0
1
1
63
William Makis
William Makis@MakisMedicine·
NEW ARTICLE: IVERMECTIN, MEBENDAZOLE and Chlorine Dioxide Testimonial - 62 year old Texas Woman with Stage 3 Breast Cancer Reports after 5 months: tumors shrinking, no conventional treatment! This is Cancer Research inspiration 😃 STORY: 62 year old Texas Woman with Stage 3 Breast Cancer In December 2025 she started: Ivermectin 1.5mg/kg/day Mebendazole 1500mg/day Chlorine Dioxide CDS orally and baths Response after 5 months: "protocol has been working nicely for me" "My latest mammogram shows a reduction in the size of both tumors, breast & lymph node after just 3 months" No conventional treatment. Cutting edge Cancer research is coming to FLORIDA! Repurposed drugs are the future of Cancer Care and Florida is going to be the global hub of repurposed drug research and innovation. 👏 I have helped over 9000 Cancer patients with Ivermectin, Mebendazole, Fenbendazole in the largest Ivermectin Cancer Project in the world! Major news coming soon! 😉 Article link in first photo at the top to avoid shadowbanning on X, just retype the URL into your browser to access.
William Makis tweet mediaWilliam Makis tweet mediaWilliam Makis tweet mediaWilliam Makis tweet media
English
22
350
1.1K
16.3K
Tulsi Gabbard 🌺
Tulsi Gabbard 🌺@TulsiGabbard·
I am deeply grateful for the trust President Trump placed in me and for the opportunity to lead @ODNIgov for the last year and a half. Unfortunately, I must submit my resignation, effective June 30, 2026. My husband, Abraham, has recently been diagnosed with an extremely rare form of bone cancer. He faces major challenges in the coming weeks and months. At this time, I must step away from public service to be by his side and fully support him through this battle.
Tulsi Gabbard 🌺 tweet media
English
43K
38K
285K
11.4M
IvermectinForLess.com
IvermectinForLess.com@IVERMECTlN·
Source: KAIST / Advanced Science (Gong et al., 2024) via ScienceDaily and OncoDaily
English
0
0
0
36
IvermectinForLess.com
IvermectinForLess.com@IVERMECTlN·
𝗧𝗵𝗲𝘆 𝗗𝗶𝗱𝗻’𝘁 𝗞𝗶𝗹𝗹 𝗧𝗵𝗲 𝗖𝗮𝗻𝗰𝗲𝗿 — 𝗧𝗵𝗲𝘆 𝗧𝗮𝘂𝗴𝗵𝘁 𝗜𝘁 𝗧𝗼 𝗕𝗲𝗰𝗼𝗺𝗲 𝗡𝗼𝗿𝗺𝗮𝗹 𝗔𝗴𝗮𝗶𝗻 This article says that researchers at KAIST in South Korea may have opened an entirely new path in cancer treatment — not by destroying cancer cells with chemotherapy or radiation, but by reversing them back into healthy cells. Led by Professor Kwang-Hyun Cho, the team created a digital model of the gene network involved in colon cancer development and identified three key regulator genes: MYB, HDAC2, and FOXA2. By controlling these molecular “switches,” they were able to push malignant colon cancer cells to behave like normal intestinal cells again. The study reportedly showed success in laboratory experiments, cell studies, and animal models, where cancer cells stopped uncontrolled growth and regained normal cellular functions. The research has now been transferred to BioRevert Inc. for further development. While this is still early-stage science and not yet a clinical cure, it suggests a future where some cancers might be reprogrammed instead of destroyed.
ScienceFocus@ScienceFocusonX

They didn't kill the cancer. They told it to go home. A team of Korean scientists at KAIST just pulled off something that sounds like science fiction. Instead of nuking colon cancer cells with chemo or radiation, they convinced them to turn back into normal, healthy colon cells. No killing. No collateral damage. Just a quiet U-turn at the cellular level. Here's how it works. Led by Professor Kwang-Hyun Cho at the Department of Bio and Brain Engineering, the team built a "digital twin" of the gene network that controls how a normal cell becomes cancerous. They ran simulations. They hunted for the exact moment a healthy cell flips into a malignant one. Then they found the switches. Three master regulator genes — MYB, HDAC2, and FOXA2 — were the keys to the whole transformation. Flip those switches back, and the cancer cell stops behaving like a cancer cell. It starts looking and acting like a normal enterocyte, the kind of cell that lines a healthy intestine. No gene editing. No permanent rewiring. Just the body's own natural signals, used in reverse. The team confirmed it in molecular experiments, cellular experiments, and animal studies. The malignant cells stopped multiplying out of control and went back to doing their actual job. The research has already been handed off to a company called BioRevert Inc. to develop into real-world treatments. This isn't a cure tomorrow. But it rewrites the entire playbook for how we think about cancer. You don't always have to destroy the enemy. Sometimes you just have to remind it who it used to be. Source: KAIST / Advanced Science (Gong et al., 2024) via ScienceDaily and OncoDaily

English
1
1
1
83
IvermectinForLess.com
IvermectinForLess.com@IVERMECTlN·
@MakisMedicine Your remarkable research in Rheumatoid Arthritis (RA) is appreciated by many people. Thank you Dr. for continuing to share hope, important research, and real patient experiences.🙏 To contact Dr. Makis: x.com/i/status/20567… Beware of fake emails and scammer. Official 👇
William Makis@MakisMedicine

@LibsEatBoogers @LoveWellLive All adults worldwide can send emails to info@makisw.com However, children will receive priority when the Clinic opens.

English
0
2
1
83
William Makis
William Makis@MakisMedicine·
NEW ARTICLE: RESEARCH: IVERMECTIN in RHEUMATOID ARTHRITIS - 2023 Paper from Pakistan What about Ivermectin and Rheumatoid Arthritis? 2023 Khan et al - Evaluation of therapeutic potential of ivermectin against complete Freund's adjuvant-induced arthritis in rats: Involvement of inflammatory mediators HIGHLIGHTS: 32 male Wistar rats were randomly divided into four groups: control, diseased, dexamethasone, and ivermectin groups After 7 days of rheumatoid arthritis induction, animals were treated with dexamethasone (steroid) 5 mg/kg and Ivermectin 6 mg/kg RESULTS: Ivermectin has no significant effect on the body weight of rats. Rat's body weight decreased in the diseased group. On Day 15 of the study, there was a significant decrease in arthritis in the dexamethasone and ivermectin groups in comparison with the diseased group there was significant increase in WBC count in the diseased group After the treatment, the WBC count was significantly decreased in the dexamethasone and Ivermectin groups There was highly significant subcutaneous inflammation, synovial inflammation, and bone erosion in the diseased group as compared with the control group Inflammation in the Ivermectin group decreased moderately and significantly as compared with the diseased group Bone erosion, cartilage erosion, pannus formation were decreased significantly in the Ivermectin group CONCLUSION: "In our study, results showed that ivermectin improved the histopathological characteristics in comparison with the diseased group" "Ultimate aim of using ivermectin was to preserve the tissue architecture, morphology, and function. Histological data suggest that it has succeeded in protecting bone and joint articulation to some extent by preventing the influx of inflammatory cells, as well as the differentiation and proliferation of osteoclasts within the joint cavity." "Our study has demonstrated that ivermectin does have anti-inflammatory and antiarthritic effects that are in some cases comparable with those of the potent corticosteroid dexamethasone." (!!) Ivermectin increased body weight, improved the visual arthritic score, and decreased WBC, neutrophils, and lymphocytes counts. Ivermectin also decreased the expression of inflammatory cytokines, TLR-2, TNF, IL-17, and NF-κB Now you can see why Big Pharma fears Ivermectin so much 😃 Ivermectin research shows impressive Ivermectin activity not only against viruses, but also against cancer and autoimmune diseases. I have helped over 9000 people with repurposed drugs: Ivermectin, Mebendazole and Fenbendazole. A small subset of the 9000 had autoimmune diseases including Rheumatoid Arthritis. Article link in first photo at the top to avoid shadowbanning, just retype the URL into your browser to access article.
William Makis tweet mediaWilliam Makis tweet mediaWilliam Makis tweet mediaWilliam Makis tweet media
English
21
301
866
22.9K
William Makis
William Makis@MakisMedicine·
NEW ARTICLE: IVERMECTIN, FENBENDAZOLE and MEBENDAZOLE Testimonial - 80 year old man with Stage 4 NSCLC Lung Cancer reports after 6 months: Oncologist shocked! Another shocked Oncologist from Massachusetts 😃 STORY: 80 year old man with Stage 4 NSCLC Lung Cancer In August 2025 he started: Ivermectin 60mg/day Fenbendazole 888mg/day In January 2026 he started: Ivermectin 72mg/day Fenbendazole 1776mg/day Mebendazole 1000mg/day Results after 6 months: “Liver tumors have shrunk significantly or completely resolved” “Lung tumors have stabilized" “Medical Oncologist is surprised. Recommends staying the course with Keytruda” "My dad appears to be tolerating the stronger protocol well. He looks a lot better and is much more mobile. He has been off all pain medication for several weeks” “The medical oncologist did not expect these results” Of course the medical Oncologist did not expect his patient to improve! 😃 There is so much truth hidden in these interactions with modern mainstream Oncology. 🤔 Always pay attention to how the Oncologist reacts - in the vast majority of cases, the Oncologist won't hold back because they don't have to... Here, the Oncologist is giving the patient a treatment (Keytruda) that costs $200,000 a year and doesn't expect the patient to actually GET BETTER. That's why he is genuinely surprised and shocked when the patient actually improves dramatically on Ivermectin, Mebendazole and Fenbendazole. Honest reaction. Oncologist still keeps their job. It's also important to point out 2 key things here: 1. It's ok for a medical Oncologist to give an 80 year old patient a $200,000 treatment and expect the patient to not get better, and only get worse. People accept that as "Normal". But imagine the patient was given $200,000 of Ivermectin and didn't improve or only got worse. That would be considered headline news and doctors would be calling for a ban on repurposed drugs. (one year's worth of Ivermectin will set you back $2000 to $4000, $200 if you get it from Indiamart pharmacy). 2. Safety. Oncologists routinely give drugs that cause horrific side effects, liver toxicity and sometimes even death. That's considered "normal". Here we have a (currently) 81 year old patient on what would be considered "high" doses of Ivermectin, Mebendazole and Fenbendazole and not only does he not have any side effects, he feels MUCH better and is off ALL pain medications! (that alone is costing Big Pharma thousands in lost profits) It's very important to point out these double standards, because mainstream Oncology is full of them. It's also important to point out the misinformation around repurposed drugs. Remember, Big Pharma stands to make $200,000/year on Keytruda vs $2000 on Ivermectin. That is a 100-fold difference in profit. "If Ivermectin worked, all Oncologists would use it" At 100 times less profit? No, they wouldn't. No one takes a 99% pay cut voluntarily. And all you have to do is have one interaction at Mayo Clinic, MD Anderson, Cleveland Clinic, Dana Farber, MSKCC, to realize medical Oncology never puts the patient first. I have helped over 9000 Cancer patients with Ivermectin, Mebendazole, Fenbendazole in the largest Ivermectin Cancer Project in the world! Now moving to FLORIDA! 🙏 Thanks to Governor DeSantis and the Florida Cancer Innovation Fund, researchers will be able to conduct cutting edge Cancer Research with repurposed drugs. Article link in first photo at the top to avoid shadowbanning on X, just retype the URL into your browser to access.
William Makis tweet mediaWilliam Makis tweet mediaWilliam Makis tweet media
English
42
573
1.6K
33.5K
Alexine
Alexine@AlexineBook·
@MakisMedicine Any studies about these meds helping against osteosarcoma?
English
10
1
11
249
IvermectinForLess.com
IvermectinForLess.com@IVERMECTlN·
𝗦𝘂𝗻 𝗘𝘅𝗽𝗼𝘀𝘂𝗿𝗲 𝗮𝗻𝗱 𝗛𝗲𝗮𝗹𝘁𝗵: 𝗪𝗵𝗮𝘁 𝗧𝗵𝗶𝘀 𝟭𝟬-𝗬𝗲𝗮𝗿 𝗔𝗻𝗮𝗹𝘆𝘀𝗶𝘀 𝗙𝗼𝘂𝗻𝗱 ☀️ This article says that higher levels of UV exposure were associated with lower all-cause mortality, a reduced burden of cardiovascular disease, and better outcomes in infectious diseases. The review also found lower incidence and mortality rates for several internal cancers among people with greater sun exposure. At the same time, the researchers noted that the effects of UV exposure are not the same across all organs. Certain cancers, including cervical and liver cancers, showed positive associations with sun exposure, highlighting the complexity of the sun’s biological effects on the body. The authors stress that public health guidance should balance the potential systemic benefits of sunlight with the known risks of skin damage and excessive exposure. ✅️ Enjoy the sun responsibly — without getting burned.
🔬 RicardoMontes@_MCRicardo_

Systemic effects of sunlight: 10-year review of cardiovascular, infection and cancer outcomes 🌞 Higher levels of UV exposure have been associated with lower all-cause mortality, reduced cardiovascular & infectious disease burden & decreased incidence and mortality for several internal malignancies. ⚠️ At the same time, UV effects are not uniform across all organ systems, as cervix uteri & liver cancer demonstrate positive associations with solar exposure. These findings highlight the complexity of sunlight's biological influence. ✅️ Sunbathe without burning. onlinelibrary.wiley.com/doi/full/10.11… @HealthyFellow @Mangan150

English
0
1
1
71
IvermectinForLess.com
IvermectinForLess.com@IVERMECTlN·
@MakisMedicine Thank you Dr. for continuing to share hope, important research, and real patient experiences.🙏 Work and dedication are appreciated. To contact Dr. Makis: x.com/i/status/20567… Please beware of fake emails and impersonators — scammers may change just one letter. Official👇
William Makis@MakisMedicine

@LibsEatBoogers @LoveWellLive All adults worldwide can send emails to info@makisw.com However, children will receive priority when the Clinic opens.

English
0
0
0
373
Commentary | Global Ivermectin Research Hub
I used Ivermectin 1.87% on a basal cell carcinoma (skin cancer) that was on the end of my nose for 3 months. The lesion stop ulcerating / bleeding. Healed and faded out from dark red to light pink to gone! Ivermectin is a miracle!
English
27
766
2.6K
56.2K
Kev A
Kev A@HurtingCanadian·
@MakisMedicine As a Canadian I want to know where he is getting the ivermectin, and mebendazole. Would like to acquire fenben also...
English
15
0
12
245
William Makis
William Makis@MakisMedicine·
NEW ARTICLE: IVERMECTIN and MEBENDAZOLE Testimonial - 51 year old Canadian man with Glioblastoma reports after 12 months - tumor continues to shrink on NO CHEMO! This Canadian Oncologist was hallucinating! 😂 STORY: 51 year old Canadian man with Glioblastoma diagnosed in July 2024. Had surgery and chemoradiation from Sep to Oct.2024 Tumor continued to grow as of Jan.2025: “growth has proven to be exponential, so we have aborted all conventional treatment except for anti-seizure meds and cortisone” In February 2025 he started: Ivermectin 1.5mg/kg/day Mebendazole 1400mg/day As of Oct.2025, Tumor has shrunk from 3.5cm to 2.8cm! No chemo! No radiation! "Oncologists...believe since there is progress in tumour shrinkage it must be and therefore are attributing the shrinkage to the chemo and radiation of last year time" Now that is one of the best hallucinations I've ever seen from an Oncologist - and no surprise - a Canadian Oncologist!! 😉 (if you know, you know) They really believed that chemo and radiation from previous year was still having an effect on the tumor one year later! Wow! 😂 The craziness we see in mainstream Oncology... I have helped over 9000 Cancer patients with Ivermectin, Mebendazole, Fenbendazole in the largest Ivermectin Cancer Project in the world! Florida announcements coming soon!! 🤫 Article link in first photo at the top to avoid shadowbanning on X, just retype the URL into your browser to access.
William Makis tweet mediaWilliam Makis tweet mediaWilliam Makis tweet mediaWilliam Makis tweet media
English
45
431
1.3K
23.9K